Recursion and Bayer Expand Fibrosis Collaboration to Include Inferential Search Capabilities
SALT LAKE CITY, Dec. 6, 2021 /PRNewswire/ -- Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology to radically improve lives by industrializing drug di…
